Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers
about
Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometryInvasive Apophysomyces variabilis infection in a burn patientSUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGYMucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia speciesAdaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibilityNovel antifungal agents: a patent review (2013 - present).Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus.Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection SAntifungal susceptibility profile of human-pathogenic species of LichtheimiaIn vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.Mucor irregularis-associated cutaneous mucormycosis: Case report and review.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesEtest cannot be recommended for in vitro susceptibility testing of mucorales.Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Our 2014 approach to mucormycosis.Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.Rare fungal infectious agents: a lurking enemy.Occurrence and species distribution of pathogenic Mucorales in unselected soil samples from France.Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)
P2860
Q24604418-05BCB5A5-7D78-45EB-9038-58793309F7F0Q24616334-0F9591BC-282D-45F3-A2C0-CA089C5668CFQ26783197-62BD42CA-E60F-4055-9458-75BE3DACD55BQ28389719-E7E078CA-C3AB-4926-BE99-6685E3CA336DQ28606369-5A14E728-2CCC-490D-9F03-1EEE322F5F4AQ30239745-C3AB2339-3216-4F6B-8421-F29113EC5DDFQ30858375-06836B70-F47F-4616-BC16-742374CECA86Q33773267-508AB7F7-E358-49B1-BCC7-79B992A8AB79Q33909379-9614BFAD-6665-458F-A5B8-00E5543E927EQ33962824-DE6790D1-3A04-4EEF-AED7-CC25E7624ABDQ34045255-9BAA1C63-DBFF-4926-9FE3-B3B88369ADF6Q34436174-5D99A4E2-888E-4ABB-8ADA-308ADC17B090Q35076896-10D90CD2-9F3E-4A1C-B8E8-9AD6D5A7B8D7Q35595623-4E119249-0EFB-49DF-8E59-FBEE09EA72A6Q35668229-141434F7-6DAE-4A78-B4C5-0720C1951EB4Q37009706-DC93DCFB-EA56-432B-84F0-686042AC8059Q37608276-C0DBC3FF-88FF-495B-8E21-AE4D7CAF30C0Q38211830-C4804D95-E394-4E1C-B378-10E400B8400DQ40965373-45362D2A-81B7-49E7-BFD7-81E716473825Q41850557-7E29056B-79EB-4365-B620-01F35DE7ED86Q42096347-06E73642-BA05-4877-8D28-BF800E4BA69CQ42151635-C40A9889-DBD3-4E1F-8C1D-589DC65FB4AEQ46258749-0262EF7C-CB0F-47D5-89F3-1DD34676750DQ46290666-4A31052F-6C0F-4619-A695-75D5C5D141D0Q46834709-E0D6237A-FE3F-4077-90CB-E077B961DF9FQ57651648-FBAF0ABA-C855-43F1-AA09-640FD8C12AE7
P2860
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activity of posaconazole and o ...... f internal transcribed spacers
@en
Activity of posaconazole and o ...... internal transcribed spacers.
@nl
type
label
Activity of posaconazole and o ...... f internal transcribed spacers
@en
Activity of posaconazole and o ...... internal transcribed spacers.
@nl
prefLabel
Activity of posaconazole and o ...... f internal transcribed spacers
@en
Activity of posaconazole and o ...... internal transcribed spacers.
@nl
P2093
P2860
P356
P1476
Activity of posaconazole and o ...... f internal transcribed spacers
@en
P2093
Ana Alastruey-Izquierdo
Araceli Monzon
Isabel Cuesta
Juan Luis Rodriguez-Tudela
Manuel Cuenca-Estrella
Maria Victoria Castelli
P2860
P304
P356
10.1128/AAC.01467-08
P407
P577
2009-01-26T00:00:00Z